Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2023-09-26 00:00:00 ET · period of report 2023-09-25 · accession 0001453687-23-000067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-26 | 2023-09-25 | RNAC | TRABER PETER G | Chief Medical Off | S - Sale | $1.06 | -705 | 451.8K | -0.2% | -$747.30 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-25 | S | D | 705 | $1.06 | 451,826 | D | — | — | (F2) Includes 6,410 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between September 1, 2022 and February 28, 2023. |